Get in touch
Please contact us to discuss how working with Myriad Associates can maximise and secure R&D funding opportunities for your business.
Helping businesses secure and maximise R&D tax credits and grants
Helping businesses secure and maximise R&D tax credits and grants
Myriad Associates is proud to announce that 4 of our clients who applied for the Disruptive Technologies Innovation Fund were all approved on Monday 10th December.
With a combined grant value of €14.9m, this will provide a major boost to the MedTech and Cellular Therapy communities in Galway.
The first 27 projects from Ireland’s €500m Disruptive Technologies Innovation Fund (DTIF) were announced this week and will receive a combined €75m in support.
Marc Greatrex, Director of Grants at Myriad Associates commented the success of these applications was a testament to the strength of concepts with the passion, drive and commitment of the SMEs in Galway “We are absolutely thrilled and humbled to have 4 out of 4 applications accepted by the DTIF, we were always hopeful and glad we could help these consortia secure the funding. The technologies they're developing will have a major impact for patients and on the Irish National Strategic Outcomes in the coming years”
The full list of approved projects can be accessed here. They include a scheme to help communities generate their own electricity, new treatments for sepsis, a support system for coastal flooding and advanced 3D printing of medical implants.
This post was written by Cale Bannister who is Marketing Executive at Myriad Associates. Click here to read more about Cale and the Myriad team.
Please contact us to discuss how working with Myriad Associates can maximise and secure R&D funding opportunities for your business.